Current disease status-In remission Posts on Medivizor
Navigation Menu

Current disease status-In remission Posts on Medivizor

Can biological therapies nivolumab and ipilimumab prevent stage IV melanoma from returning?

Can biological therapies nivolumab and ipilimumab prevent stage IV melanoma from returning?

Posted by on Jun 6, 2020 in Melanoma | 0 comments

In a nutshell This study examined if biological therapies nivolumab (Opdivo) and ipilimumab (Yervoy) could safely prevent cancer return in patients with stage IV melanoma that has been surgically removed. The results showed that nivolumab and ipilimumab were effective at preventing recurrence but nivolumab alone was safer for patients. Some...

Read More

The effects of continued blinatumomab therapy in adult patients with relapsed/refractory acute lymphoblastic leukemia

Posted by on May 3, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated treatment outcomes in patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) who continued blinatumomab (Blincyto; BL) after initial therapy. The authors found that long-term BL therapy can improve survival in these patients. Some background 45% of adults with ALL experience R/R...

Read More

Surviving cancer – is there a greater risk of cardiovascular disease long-term?

Posted by on Sep 16, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated if there is a higher risk of cardiovascular disease (CVD) in cancer survivors.  They found that cancer survivors have a higher risk of CVD. Some background Improved cancer detection and treatment has increased the rates of survival. The number of cancer survivors living for more than 10 years is growing. Some...

Read More

Surviving cancer – is there a greater risk of cardiovascular disease long-term?

Posted by on Sep 16, 2019 in Leukemia | 0 comments

In a nutshell This study investigated if there is a higher risk of cardiovascular disease (CVD) in cancer survivors.  They found that cancer survivors have a higher risk of CVD. Some background Improved cancer detection and treatment has increased the rates of survival. The number of cancer survivors living for more than 10 years is growing. Some...

Read More

Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy

Posted by on Aug 21, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the use of testosterone replacement therapy (TRT) in men who had definitive treatment for prostate cancer. The authors concluded that TRT was not associated with a higher risk of recurrence in these patients. Some background Prostate cancer (PCa) is commonly fueled by the sex hormone testosterone....

Read More

Anxiety and depression risk in childhood survivors of ALL

Posted by on Oct 4, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the risk of anxiety and depression in patients who survived acute lymphoblastic leukemia (ALL) in childhood. The study found that factors such as fatigue, poor sleep, and mental function increased the risk of anxiety and depression in these patients. Some background Acute Lymphoblastic Leukemia (ALL) is a cancer...

Read More

Evaluating the long-term risk of cardiovascular mortality in lymphoma survivors

Posted by on Aug 28, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study investigated the long-term risk of cardiovascular mortality (death due to heart and blood vessel disease) among lymphoma survivors, compared to the general population. This study concluded that lymphoma survivors have a higher cardiovascular mortality risk compared to the general population.  Some background Advances in...

Read More

Does graft versus host disease affect relapse and survival rates after a stem cell transplant in childhood leukemia?

Posted by on Jul 13, 2018 in Leukemia | 0 comments

In a nutshell This study examined the effect of graft versus host disease on relapse rates in children with acute leukemia. This study concluded that graft versus host disease may protect against relapse, but they did not see an effect on survival. Some background One complication following an allogeneic stem cell transplant (transplant using donor...

Read More

Hodgkin lymphoma and thyroid cancer

Posted by on May 31, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined whether Hodgkin lymphoma survivors were more likely to develop more aggressive forms of thyroid cancer than the general population. The authors concluded that a history of Hodgkin lymphoma was not associated with aggressive subtypes or worse outcomes of thyroid cancer. Some background Hodgkin lymphoma survivors are at...

Read More

Can tyrosine kinase inhibitor treatment be stopped in CML patients with deep molecular response?

Posted by on May 29, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to define the conditions necessary for stopping tyrosine kinase inhibitor treatment in patients with chronic myeloid leukemia. This study concluded that patients who maintain a deep molecular response have good molecular relapse-free survival and can be considered for treatment discontinuation. Some...

Read More